The present invention provides for a compound having the structure: (AA.sub.1).sub.n-Cys-(AA.sub.2).sub.m wherein n=0,1,2,3,4 or 5 and m=0,1,2,3,4 or 5, provided the sum of (n+m) is greater than or equal to two and less than or equal to five, if n=1, (AA.sub.1).sub.n=Ala-, if n=2, (AA.sub.1).sub.n=Gln-Ala-, if n.gtoreq.3, (AA.sub.1).sub.n=(Xaa).sub.p-Gln-Ala-, and Xaa=any amino acid and wherein if n=n3, p=1, if n=4, p=2, if n=5, p=3, if m=1, (AA.sub.2).sub.m=-Arg, if m=2, (AA.sub.2).sub.m=-Arg-Gly, if m.gtoreq.3, (AA.sub.2).sub.m=-Arg-Gly-(Xaa).sub.q, wherein if m=3, q=1, if m=4, q=2, if m=5, q=3. The present invention provides for a method of inhibiting cell death and a method for alleviating symptoms of a neurodegenerative disorder in a subject.

 
Web www.patentalert.com

< Encapsulated fragrance chemicals

< Nicotinamide derivatives useful as p38 inhibitors.

> Compounds useful in the manufacture of an anti-inflammatory androstane derivative

> Polyhydroxyalkanoate-containing structure and manufacturing method thereof

~ 00298